Kim Jong Joseph
SEC CIK 1464549 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INO | INOVIO PHARMACEUTICALS, INC. | CEO, Dir | 1.46M | — | — | 6 | 2022-02-26 | 2022-03-11 |
Most active insiders at INO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sumner Michael John | Chief Medical Off | — | — |
| 2 | Shea Jacqueline Elizabeth | CEO, Dir | — | — |
| 3 | Humeau Laurent | CSO | — | — |
| 4 | Weiner David B. | Dir | — | — |
| 5 | KIES PETER | CFO | — | — |
Kim Jong Joseph made no open-market trades at INO in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-14 | 2022-03-11 | INO | INOVIO PHARMACEUTICALS, INC. | Kim Jong Joseph | CEO, Dir | M - OptEx | — | +139.4K | 1.46M | +11% | — |
| D | 2022-03-14 | 2022-03-11 | INO | INOVIO PHARMACEUTICALS, INC. | Kim Jong Joseph | CEO, Dir | F - Tax | $3.22 | -39.7K | 1.42M | -3% | -$127.8K |
| D | 2022-03-09 | 2022-03-08 | INO | INOVIO PHARMACEUTICALS, INC. | Kim Jong Joseph | CEO, Dir | M - OptEx | — | +63.7K | 1.34M | +5% | — |
| D | 2022-03-09 | 2022-03-08 | INO | INOVIO PHARMACEUTICALS, INC. | Kim Jong Joseph | CEO, Dir | F - Tax | $3.26 | -18.1K | 1.32M | -1% | -$59.1K |
| D | 2022-03-01 | 2022-02-26 | INO | INOVIO PHARMACEUTICALS, INC. | Kim Jong Joseph | CEO, Dir | M - OptEx | — | +68.8K | 1.30M | +6% | — |
| D | 2022-03-01 | 2022-02-26 | INO | INOVIO PHARMACEUTICALS, INC. | Kim Jong Joseph | CEO, Dir | F - Tax | $3.22 | -20.0K | 1.28M | -2% | -$64.5K |
Purchase Sale Sale after option exercise All abbreviations